Assessment of the effective absorbed dose of 4-benzyl-1-(3-[125I]-iodobenzylsulfonyl)piperidine in humans on the basis of biodistribution data of rats

Nuclear Medicine Communications

Volumn 36, Issue 1, 2015, Pages 90-94

  Sadeghzadeh, Masoud ^a   Shanehsazzadeh, Saeed ^a   Lahooti, Afsaneh ^b  

^a NUCLEAR SCIENCE AND TECHNOLOGY RESEARCH INSTITUTE   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

4 benzyl 1 (3 125I iodobenzylsulfonyl)piperidine; Biodistribution; Effective absorbed dose; MIRD; Sigma 1 receptor ligand

Indexed keywords

4 BENZYL 1 (3 ODOBENZYLSULFONYL) PIPERIDINE I 125; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 4-BENZYL-1-(3-IODOBENZYLSULFONYL)PIPERIDINE; PIPERIDINE; PIPERIDINE DERIVATIVE; SULFONAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DOSE CALCULATION; DRUG BONE LEVEL; DRUG BRAIN LEVEL; DRUG MUSCLE LEVEL; FEMALE; HUMAN; IN VIVO STUDY; ISOTOPE LABELING; NONHUMAN; RADIATION ABSORPTION; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RAT; SKIN ABSORPTION; THYROID GLAND; TISSUE DISTRIBUTION; ANIMAL;

ANIMALS; FEMALE; HUMANS; PIPERIDINES; RADIATION DOSAGE; RATS; SULFONAMIDES; TISSUE DISTRIBUTION;

EID: 84913529631     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0000000000000210     Document Type: Article

References (31)

1. Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE. The effects of morphine- and nalorphine-like drugs in the nondependent and morphinedependent chronic spinal dog. J Pharmacol Exp Ther 1976; 197:517-532.
2. Abou-Gharbia M, Ablordeppey SY, Glennon RA. Sigma receptors and their ligands: the sigma enigma. Annu Rep Med Chem 1993; 28:1-10.
3. Bowen WD. Sigma receptors: recent advances and new clinical potentials. Pharm Acta Helv 2000; 74:211-218.
4. Wolfe SA Jr, Ha BK, Whitlock BB, Saini P. Differential localization of three distinct binding sites for sigma receptor ligands in rat spleen. J Neuroimmunol 1997; 72:45-58.
5. Whitlock BB, Liu Y, Chang S, Saini P, Ha BK, Barrett TW, Wolfe SA Jr. Initial characterization and autoradiographic localization of a novel sigma/opioid binding site in immune tissues. J Neuroimmunol 1996; 67:83-96.
6. Guitart X, Codony X, Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) 2004; 174:301-319.
7. Akhter N, Shiba K, Ogawa K, Tsuji S, Kinuya S, Nakajima K, Mori H. A change of in vivo characteristics depending on specific activity of radioiodinated (+)-2-[4-(4-iodophenyl)piperidino]cyclohexanol [(+)-pIV] as a ligand for sigma receptor imaging. Nucl Med Biol 2008; 35:29-34.
8. 11C]SA4503 for imaging of sigma receptors in tumors by animal PET. Ann Nucl Med 2005; 19:701-709.
9. Chu W, Xu J, Zhou D, Zhang F, Jones LA, Wheeler KT, Mach RH. New N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl phenylcarbamate analogs as sigma2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents. Bioorg Med Chem 2009; 17:1222-1231.
10. 123I]1-(4-cyanobenzyl)-4-[[(trans-iodopropen-2-yl)oxy]methyl]piperidine: a novel high affinity sigma receptor radioligand for SPECT. Nucl Med Biol 1997; 24:45-51.
11. 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models. Nucl Med Biol 1997; 24:587-593.
12. 67Ga-DTPA-ACTH based on distribution data in rats. Radiat Prot Dosimetry 2009; 134:79-86.
13. 67Ga-cDTPA-gonadorelin based on biodistribution rat data. Nucl Med Commun 2011; 32:37-43.
14. Lahooti A, Shanehsazzadeh S, Jalilian AR, Tavakoli MB. Assessment of effective absorbed dose of (111)In-DTPA-Buserelin in human on the basis of biodistribution rat data. Radiat Prot Dosimetry 2013; 154:1-8.
15. Khorrami Moghaddam A, Reza Jalilian A, Hayati V, Shanehsazzadeh S. Determination of human absorbed dose of 201Tl(III)-DTPA-HIgG based on biodistribution data in rats. Radiat Prot Dosimetry 2010; 141:269-274.
16. Sadeghzadeh M, Sheibani S, Ghandi M, Daha FJ, Amanlou M, Arjmand M, Hasani Bozcheloie A. Synthesis and receptor binding studies of novel 4,4-disubstituted arylalkyl/arylalkylsulfonyl piperazine and piperidine-based derivatives as a new class of sigma1 ligands. Eur J Med Chem 2013; 64:488-497.
17. Sadeghzadeh M, Johari Daha f, Sheibani S, Erfani M. Radioiodination of 4-benzyl-1-(3-iodobenzylsulfonyl)piperidine, 4-(3-iodobenzyl)-1-(benzylsulfonyl)piperazine and their derivatives via isotopic and non-isotopic exchange reactions. J Radioanal Nucl Chem (in press) DOI: 10.1007/s10967-014-3347-z.
18. 111In]-rituximab immunoconjugates. Sci Pharm 2008; 76:151-170.
19. 61Cu] pyruvaldehyde-bis (N-4-methylthiosemicarbazone) in normal rats as a PET tracer. Nucl Sci Tech 2008; 19:159-164.
20. 67Ga]-DTPA-gonadorelin in normal rats. J Radioanal Nucl Chem 2008; 278:123-129.
21. 67Ga]-DTPAUSPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers. Nucl Med Commun 2013; 34:915-925.
22. Lahooti A, Shanehsazzadeh S, Oghabian MA, Allen BJ. Assessment of human effective absorbed dose of Tc-99m-USPIO based on biodistribution rat data. Hoboken, NJ, USA: Wiley-Blackwell; 2013.
23. Council B. Guidelines on the use of living animals in scientific investigations: biological council. London: Institute of Biology; 1987.
24. Shanehsazzadeh S, Oghabian MA, Daha FJ, Amanlou M, Allen BJ. Biodistribution of ultra small superparamagnetic iron oxide nanoparticles in BALB mice. J Radioanal Nucl Chem 2013; 295:1517-1523.
25. 125I in a radionuclide calibrator. Nucl Med Commun 1991; 12:445-450.
26. 111In]-DTPA-buserelin for GnRH receptor studies. Radiochim Acta 2010; 98:113-119.
27. Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. Sixth International Radiopharmaceutical Dosimetry Symposium Oak Ridge. Gatlinburg, TN: Oak Ridge Associated Universities; 1996. pp. 705-716.
28. Bevelacqua J. Internal dosimetry primer. Radiat Prot Manage 2005; 22:7.
29. Snyder W, Ford M, Warner G, Watson S. S" absorbed dose per unit cumulated activity for selected radionuclides and organs. MIRD Pamphlet No. 11. New York: Society of Nuclear Medicine; 1975.
30. 18F-fluorocholine. J Nucl Med 2002; 43:92-96.
31. [No authors listed]. The 2007 recommendations of the International Commission on Radiological Protection. ICRP publication 103. Ann ICRP 2007; 37:1-332.